Peter Thiel's Palantir scores contract with the FDA to speed up regulatory reviews as delays keep growing
Peter Thiel, the billionaire libertarian who quietly backed away in 2020 from his once-ardent support of President Donald Trump, is no stranger to government contracts. His company Palantir has secured dozens of contracts with the feds and now has another big fish on the hook.
Palantir, the Denver-based data and analytics company Thiel co-founded in 2003, entered into an agreement this week with the FDA as the government agency struggles to keep up with a surge of regulatory approval needs due to the Covid-19 pandemic.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.